Potential Use of Meoflazine as a Cardioprotective Agent: A Specific Blocker of the Ischaemic CA Channel?

Wood, A.; Parker, J.; Hynd, J.; Isted, K.; Main, M.J.; Drake-Holland, A.J.

doi:10.1042/cs066002Pb_pt2

Skip Nav Destination

Article navigation

Conference Abstract| February 01 1984

Potential Use of Meoflazine as a Cardioprotective Agent: A Specific Blocker of the Ischaemic CA Channel?

A. Wood;

A. Wood

¹ Department of Cardiothoracic Surgery, St. George's Hospital, London, SW17 0RE

Search for other works by this author on:

This Site

PubMed

Google Scholar

J. Parker;

J. Parker

¹ Department of Cardiothoracic Surgery, St. George's Hospital, London, SW17 0RE

Search for other works by this author on:

This Site

PubMed

Google Scholar

J. Hynd;

J. Hynd

¹ Department of Cardiothoracic Surgery, St. George's Hospital, London, SW17 0RE

Search for other works by this author on:

This Site

PubMed

Google Scholar

K. Isted;

K. Isted

3St. George's Hospital, London, SW17 0RE

Search for other works by this author on:

This Site

PubMed

Google Scholar

M.J. Main;

M.J. Main

² Department of Medicine, London, SW17 0RE

Search for other works by this author on:

This Site

PubMed

Google Scholar

A.J. Drake-Holland

² Department of Medicine, London, SW17 0RE

Search for other works by this author on:

This Site

PubMed

Google Scholar

Author and article information

Publisher: Portland Press Ltd

Online ISSN: 1470-8736

Print ISSN: 0143-5221

1984

Clin Sci (Lond) (1984) 66 (2): 2P–3P.

https://doi.org/10.1042/cs066002Pb_pt2

You do not currently have access to this content.

Don't already have an account? Register

You could not be signed in. Please check your email address / username and password and try again.

Portland Press

Registered address – First Floor, 10 Queen Street Place, London EC4R 1BE
Mailing address – 1 Naoroji Street, London WC1X 0GB

Portland Press Tel
+44 (0)20 3880 2795
Portland Press Company no. 02453983

Biochemical Society Tel
+44 (0)20 3880 2793
Email: editorial@portlandpress.com

Biochemical Society Company no. 00892796
Registered Charity no. 253894
VAT no. GB 523 2392 69

Privacy and cookies
Accessibility

Potential Use of Meoflazine as a Cardioprotective Agent: A Specific Blocker of the Ischaemic CA Channel?

Article PDF first page preview

Get Access To This Article

Buy This Article

Cited By

Get Email Alerts

CONNECT

EXPLORE

Cover Image

Potential Use of Meoflazine as a Cardioprotective Agent: A Specific Blocker of the Ischaemic CA Channel?

Article PDF first page preview

Sign in

Sign in to your personal account

Biochemical Society Member Sign in

Sign in via your Institution

Get Access To This Article

Buy This Article

Cited By

Get Email Alerts

CONNECT

EXPLORE

This Feature Is Available To Subscribers Only